IgA nephropathy: Difference between revisions
Line 37: | Line 37: | ||
==[[IgA nephropathy screening|Screening]]== | ==[[IgA nephropathy screening|Screening]]== | ||
== [[IgA nephropathy natural history|Natural History, Complications and Prognosis]] == | == [[IgA nephropathy natural history, complications and prognosis|Natural History, Complications and Prognosis]] == | ||
== Diagnosis == | == Diagnosis == |
Revision as of 22:38, 27 September 2012
For patient information click here Template:DiseaseDisorder infobox
IgA nephropathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
IgA nephropathy On the Web |
American Roentgen Ray Society Images of IgA nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and keywords: IgA nephritis; IgAN; Berger's disease; synpharyngitic glomerulonephritis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating IgA nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies